Elanco Animal Health (ELAN) vs Spyre Therapeutics (SYRE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Spyre Therapeutics (SYRE) has outperformed Elanco Animal Health (ELAN) over the past year, gaining 285.3% versus a gain of 15.7%. Over five years, ELAN leads with a -14.8% price change compared with -42.0% for SYRE. Elanco Animal Health is the larger company by market cap ($12.87 billion vs $8.88 billion), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAN | SYRE |
|---|---|---|
| Share price | $25.74 | $93.47 |
| Market cap | $12.87B | $8.88B |
| 1-day change | -2.09% | -4.26% |
| YTD return | +13.74% | +185.32% |
| 1-year return | +15.69% | +285.28% |
| 5-year return | -14.82% | -42.03% |
| Forward P/E | 19.91 | — |
| EPS (TTM) | $-0.30 | $-2.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.71B | $0 |
| Revenue growth (YoY) | +6.22% | — |
| Net income (latest FY) | $-232.00M | $-155.20M |
| Gross margin | 54.99% | — |
| Net margin | -4.92% | — |
| 52-week high | $27.98 | $110.64 |
| 52-week low | $19.40 | $24.58 |
| Distance from 52-week high | -8.01% | -15.52% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +20.44% | +32.52% |
| Average volume | 5.32M | 1.26M |
| Shares outstanding | 499.83M | 94.97M |
| Employees | 9,400 | 130 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SYRE has outperformed ELAN by 269.6 percentage points over the past year.
About Elanco Animal Health
ELAN stock →Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
Health Care · Biotechnology: Pharmaceutical Preparations · 9,400 employees
About Spyre Therapeutics
SYRE stock →Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease); and SPY002 and SPY072 anti-TL1A mAbs designed to bind to tumor necrosis factor-like ligand 1A (TL1A).
Health Care · Biotechnology: Pharmaceutical Preparations · 130 employees
ELAN vs SYRE FAQ
Which is bigger, Elanco Animal Health or Spyre Therapeutics?
Elanco Animal Health (ELAN) is larger, with a market capitalization of $12.87B compared with $8.88B for Spyre Therapeutics (SYRE).
Which stock has performed better over the past year, ELAN or SYRE?
SYRE returned +285.28% over the past 12 months, compared with +15.69% for ELAN (price return, excluding dividends). Past performance does not predict future results.
Are Elanco Animal Health and Spyre Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.